| Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association B Taylor, E Miller, CP Farrington, MC Petropoulos, I Favot-Mayaud, J Li, ... The Lancet 353 (9169), 2026-2029, 1999 | 1287 | 1999 |
| Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study E Miller, NJ Andrews, PA Waight, MPE Slack, RC George The Lancet infectious diseases 11 (10), 760-768, 2011 | 766 | 2011 |
| Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study PA Waight, NJ Andrews, SN Ladhani, CL Sheppard, MPE Slack, E Miller The Lancet infectious diseases 15 (5), 535-543, 2015 | 699 | 2015 |
| Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study NJ Andrews, PA Waight, P Burbidge, E Pearce, L Roalfe, M Zancolli, ... The Lancet infectious diseases 14 (9), 839-846, 2014 | 577 | 2014 |
| Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study S Flasche, AJ Van Hoek, E Sheasby, P Waight, N Andrews, C Sheppard, ... PLoS medicine 8 (4), e1001017, 2011 | 325 | 2011 |
| Idiopathic thrombocytopenic purpura and MMR vaccine E Miller, P Waight, CP Farrington, N Andrews, J Stowe, B Taylor Archives of disease in childhood 84 (3), 227-229, 2001 | 306 | 2001 |
| Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales NJ Andrews, PA Waight, RC George, MPE Slack, E Miller Vaccine 30 (48), 6802-6808, 2012 | 293 | 2012 |
| The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England AJ Van Hoek, N Andrews, PA Waight, J Stowe, P Gates, R George, ... Journal of Infection 65 (1), 17-24, 2012 | 287 | 2012 |
| Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine E Miller, NJ Andrews, PA Waight, MPE Slack, RC George Vaccine 29 (49), 9127-9131, 2011 | 263 | 2011 |
| Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis WS Hart, E Miller, NJ Andrews, P Waight, PK Maini, S Funk, ... The Lancet Infectious Diseases 22 (5), 603-610, 2022 | 242 | 2022 |
| Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010 RG Pebody, E McLean, H Zhao, P Cleary, S Bracebridge, K Foster, ... Eurosurveillance 15 (20), 19571, 2010 | 233 | 2010 |
| Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England AJ Van Hoek, CL Sheppard, NJ Andrews, PA Waight, MPE Slack, ... Vaccine 32 (34), 4349-4355, 2014 | 220 | 2014 |
| Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label … CS Waddington, WT Walker, C Oeser, A Reiner, T John, S Wilkins, ... Bmj 340, 2010 | 190 | 2010 |
| Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a … SN Ladhani, NJ Andrews, J Southern, CE Jones, G Amirthalingam, ... Clinical infectious diseases 61 (11), 1637-1644, 2015 | 185 | 2015 |
| Long-term protection against carriage of hepatitis B virus after infant vaccination MAB Sande, P Waight, M Mendy, P Rayco-Solon, P Hutt, T Fulford, ... The Journal of infectious diseases 193 (11), 1528-1535, 2006 | 159 | 2006 |
| A randomized, observer-blinded immunogenicity trial of Cervarix® and Gardasil® human papillomavirus vaccines in 12-15 year old girls E Draper, SL Bissett, R Howell-Jones, P Waight, K Soldan, M Jit, ... PloS one 8 (5), e61825, 2013 | 154 | 2013 |
| Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes AJ Van Hoek, N Andrews, PA Waight, R George, E Miller PloS one 7 (7), e39150, 2012 | 150 | 2012 |
| Invasive pneumococcal disease in England and Wales: vaccination implications K Sleeman, K Knox, R George, E Miller, P Waight, D Griffiths, A Efstratiou, ... The Journal of infectious diseases 183 (2), 239-246, 2001 | 144 | 2001 |
| Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation DJC Miles, M van der Sande, D Jeffries, S Kaye, J Ismaili, O Ojuola, ... Journal of virology 81 (11), 5766-5776, 2007 | 135 | 2007 |
| Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in … R Borrow, N Andrews, H Findlow, P Waight, J Southern, A Crowley-Luke, ... Clinical and Vaccine Immunology 17 (1), 154-159, 2010 | 134 | 2010 |
